Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1339473

Impact of Hashimoto's Thyroiditis on the Tumor Microenvironment in Papillary Thyroid Cancer: Insights from Single-Cell Analysis

Provisionally accepted
Hongzhe Ma Hongzhe Ma 1Guoqi Li Guoqi Li 1Diwei Huo Diwei Huo 2Yangguang Su Yangguang Su 1Qing Jin Qing Jin 1Yangxu Lu Yangxu Lu 1Denan Zhang Denan Zhang 1*Xiujie Chen Xiujie Chen 1*
  • 1 Harbin Medical University, Harbin, Heilongjiang, China
  • 2 The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China

The final, formatted version of the article will be published soon.

    This study investigates the impact of Hashimoto's thyroiditis (HT), an autoimmune disorder, on papillary thyroid cancer (PTC) microenvironment using a dataset of 140,456 cells from 11 patients. By comparing PTC cases with and without HT, we identify HT-specific cell populations (HASC) and their role in creating a TSH-suppressive environment via mTE3, nTE0, and nTE2 thyroid cells. These cells facilitate intricate immune-stromal communication through the MIF-(CD74+CXCR4) axis, emphasizing immune regulation in the TSH context. In the realm of personalized medicine, our HASC-focused analysis within the TCGA-THCA dataset validates the utility of HASC profiling for guiding tailored therapies. Moreover, we introduce a novel, objective method to determine K-means clustering coefficients in copy number variation inference from bulk RNA-seq data, mitigating the arbitrariness in conventional coefficient selection. Collectively, our research presents a detailed single-cell atlas illustrating HT-PTC interactions, deepening our understanding of HT's modulatory effects on PTC microenvironments. It contributes to the understanding of autoimmunity-carcinogenesis dynamics and charts a course for discovering new therapeutic targets in PTC, advancing cancer genomics and immunotherapy research.

    Keywords: Single-Cell Analysis, thyroid-stimulating hormone, immune cell communication, Cancer genomics, TCGA-THCA

    Received: 05 Dec 2023; Accepted: 05 Jul 2024.

    Copyright: © 2024 Ma, Li, Huo, Su, Jin, Lu, Zhang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Denan Zhang, Harbin Medical University, Harbin, 130012, Heilongjiang, China
    Xiujie Chen, Harbin Medical University, Harbin, 130012, Heilongjiang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.